Component: (Network and Table)
Network
00400 - Statement - Consolidated Statements of Cash Flows
(http://www.insmed.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001104506 (http://www.sec.gov/CIK)
Consolidated Statements of Cash FlowsPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Consolidated Statements of Cash Flows
 
 
 
Operating activities
 
 
 
Net loss
(176,273,000) 
(118,183,000) 
(79,159,000) 
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
Depreciation and amortization
2,438,000  
1,982,000  
1,073,000  
Stock based compensation expense
18,039,000  
15,590,000  
11,328,000  
Loss on sale of asset, net
  
9,000  
Amortization of debt issuance costs
281,000  
458,000  
390,000  
Accrual of the end of term charge on the debt
171,000  
76,000  
110,000  
Changes in operating assets and liabilities:
 
 
 
Prepaid expenses and other assets
191,000  
(1,484,000) 
(2,972,000) 
Accounts payable
2,767,000  
(1,781,000) 
3,312,000  
Accrued expenses and other
5,678,000  
2,642,000  
1,493,000  
Net cash used in operating activities
(146,708,000) 
 
(100,700,000) 
 
(64,416,000) 
 
Investing activities
 
 
 
Purchase of fixed assets
(4,200,000) 
(3,454,000) 
(5,351,000) 
Proceeds from sale of asset
  
10,000  
Net cash used in investing activities
(4,200,000) 
 
(3,454,000) 
 
(5,341,000) 
 
Financing activities
 
 
 
Payments on capital lease obligations
  
(64,000) 
Proceeds from issuance of debt
30,000,000  
 
5,000,000  
Proceeds from issuance of common stock
 
222,942,000  
109,013,000  
Proceeds from exercise of stock options
1,084,000  
5,112,000  
1,390,000  
Payment of debt issuance costs
(411,000) 
(250,000) 
(250,000) 
Net cash provided by financing activities
30,673,000  
 
227,804,000  
 
115,089,000  
 
Effect of exchange rates on cash and cash equivalents
(50,000) 
  
Net (decrease) increase in cash and cash equivalents
(120,285,000) 
 
123,650,000  
 
45,332,000  
 
Cash and cash equivalents at beginning of period
282,876,000  
159,226,000  
113,894,000  
Cash and cash equivalents at end of period
162,591,000  
 
282,876,000  
 
159,226,000  
 
Supplemental disclosures of cash flow information:
 
 
 
Cash paid for interest
3,608,000  
2,948,000  
1,803,000  
Cash (paid) received for taxes, net
(85,000) 
3,008,000  
9,429,000